|1.||Leucht, Stefan: 23 articles (02/2015 - 02/2002)|
|2.||Komossa, Katja: 14 articles (01/2014 - 01/2009)|
|3.||Rummel-Kluge, Christine: 14 articles (01/2014 - 01/2009)|
|4.||Kissling, Werner: 14 articles (01/2012 - 02/2002)|
|5.||Hunger, Heike: 13 articles (01/2013 - 01/2009)|
|6.||Schwarz, Sandra: 13 articles (01/2013 - 01/2009)|
|7.||Fleischhacker, W Wolfgang: 10 articles (09/2014 - 12/2003)|
|8.||Schmid, Franziska: 10 articles (01/2012 - 01/2009)|
|9.||Peuskens, Joseph: 8 articles (09/2014 - 01/2002)|
|10.||Kahn, René S: 8 articles (09/2014 - 10/2005)|
|1.||Schizophrenia (Dementia Praecox)
04/01/2010 - "This demonstrated significant improvement in subjective well-being in patients with schizophrenia initiating treatment with amisulpride, and a correlation between this improvement and amelioration of psychopathology. "
01/01/2002 - "Amisulpride is clinically effective on the negative symptoms of acute schizophrenia exacerbations at low dosages (50-300 mg/day), and also on the positive symptoms of the disease at high dosages (400-800 mg/day). "
09/01/1986 - "These results also suggest that sultopride would have good therapeutic efficacy in schizophrenic disorders."
01/01/2010 - "Amisulpride is effective in acute schizophrenia as determined by Clinical Global Impression scores. "
07/01/1998 - "In conclusion, 600-1 200 mg/d of amisulpride is an effective and well tolerated treatment of schizophrenic disorders, as demonstrated through this 3-month study carried in a large sample of 445 patients. "
01/01/2008 - "Observational drug-utilization studies suggest that many physicians switch to amisulpride because of fewer EPS and/or less weight gain and improved patient adherence. "
06/01/2015 - "The mean weight gain with amisulpride at 4 weeks was 2.73 kg (5.21%) and at 8 weeks was 4.34 kg (8.28%) from the baseline. "
05/01/2006 - "Acute weight gain induced by amisulpride monotherapy in a first-episode schizophrenic patient."
04/01/2004 - "Amisulpride is an atypical antipsychotic associated with low weight gain."
04/01/2004 - "To analyse the weight gain associated with amisulpride. "
|3.||Body Weight (Weight, Body)
12/01/2009 - "In this open-label 1-year study, we investigated the effects on body weight and other metabolic profiles when psychiatric patients treated with another SGA were switched to amisulpride treatment. "
05/01/2006 - "However, the patient gained 12.9 kg of body weight in the first 2 months of amisulpride administration and a total of 17.3 kg, 6 months after initiation of the treatment. "
01/01/2002 - "Amisulpride offers a significant advantage in preserving body weight."
11/08/1999 - "Patients receiving risperidone experienced an increase in body weight, which was significantly greater than for amisulpride (P = 0.026)."
05/01/2007 - "We have assessed the evolution of body weight and glycaemia during a 6-month randomized comparative trial of amisulpride and olanzapine. "
|4.||Major Depressive Disorder (Major Depressive Disorders)
01/01/2013 - "Brain morphology changes in a remitted patient with late-onset, drug-naïve, non-psychotic major depressive disorder after amisulpride monotherapy."
05/01/2005 - "Amisulpride is a selective D(2)-D(3) antagonist that has been reported to be effective in the treatment of schizophrenia and major depressive disorder. "
01/01/2010 - "We serendipitous observed an increase tolerability, a rapid response to therapy and an early onset of antidepressant fluvoxamine activity when associated with amisulpride in patients with major depressive disorder. "
01/01/2010 - "Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder."
01/01/2006 - "Amisulpride is an atypical antipsychotic that has been proven to be effective in treatment of schizophrenia, major depressive disorder and, more recently, acute mania. "
01/01/2006 - "The tic-like symptoms resolved completely after we reduced the dose of amisulpride down to 800 mg per day. "
05/01/2006 - "Tics improved and finally disappeared after amisulpride withdrawal. "
05/01/2006 - "Tardive motor and phonic tics should be considered as a possible adverse effect of amisulpride."
05/01/2006 - "A 55-year-old woman developed motor and phonic tics after a prolonged treatment with amisulpride. "
05/01/2006 - "To report a patient with tardive tics possibly induced by the atypical neuroleptic drug amisulpride. "
|2.||Risperidone (Risperdal Consta)
|3.||Antipsychotic Agents (Antipsychotics)
|3.||Drug Therapy (Chemotherapy)
|4.||Activities of Daily Living (ADL)